Multi-disciplinary Thoracic Oncology: State-of-the-art and new directions
NewYork-Presbyterian Clinicians – $60
Clinicians (non-NYP) – $120
Fellows, Residents & Students (no CME credits will be awarded) – FREE
NewYork-Presbyterian/Columbia University Medical Center
Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
173 Fort Washington Avenue, First Floor
New York, NY 10032
Balazs Halmos, MD
Jeffrey L. Port, MD
Ronald J. Scheff, MD
Joshua R. Sonett, MD, FACS
This one day CME accredited educational course will focus on significant updates on the state-of-the-art screening, work-up, diagnosis, staging and treatment of thoracic malignancies highlighting the need of multi-disciplinary management of complex diseases, such as small cell and non-small cell lung cancer, thymic malignancies and mesothelioma. Two major sessions will review management aspects of curable stages of non-small cell lung cancer as well as other less common thoracic malignancies. A keynote presentation, given by an internationally recognized thought leader, will review major updates from the 2014 ASCO meeting. One major session will be dedicated to provide updates on major progress made in the management of advanced non-small cell lung cancer through molecular testing, targeted and immunotherapies. Challenging case presentations presented in a Tumor Board format will highlight key management aspects of complex cases and attendee participation and interaction will be facilitated through Q&A and interactive panel discussions.
- Define the appropriate implementation of CT screening for lung cancer in high-risk patients and work-up of findings
- Recognize recent advancements in surgical, radiation and chemotherapy treatments for patients with curable non-small cell lung cancer
- Discuss the multi-disciplinary treatment of less common thoracic malignancies, such as thymoma, small cell lung cancer and mesothelioma
- Explain recent progress in the management of advanced non-small cell lung cancer through use of state-of-the-art molecular testing approaches and novel targeted and immunotherapies
- Identify the incorporation of findings into day-to-day practice setting through presentations and discussions of complex and challenging cases
This activity is designed for internists, medical and radiation oncologists, nurses, physician assistants, pulmonologists, radiologists, respiratory therapists, thoracic surgeons, and other medical professionals involved in the screening and evaluation of high-risk patients as well as the diagnosis, staging and/or management of patients with thoracic malignancies.
The College of Physicians and Surgeons of Columbia University is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
The College of Physicians and Surgeons designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and physician assistants are encouraged to check with their accrediting organization to ensure they accept AMA PRA Category 1 Credits™.
We expect support for this program through grants from pharmaceutical and medical device companies.
Parking is available at the NewYork-Presbyterian/Columbia University Medical Center parking garage, located on the southwest corner of Fort Washington Avenue and West 165th Street. Parking fee is NOT included with registration.
Take the 1, A, C lines to 168th Street — Washington Heights/Broadway.
Educational Grant/Exhibit Support Interest
If you are interested in supporting this medical education program with an educational grant and/or an exhibit, please contact Medical Education Liaison Christine Rein at:
Medical Education Liaison
Columbia University Medical Center
Department of Surgery, External Affairs